Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2026-02-22 @ 9:39 AM
Study NCT ID:
NCT02957032
Status:
TERMINATED
Last Update Posted:
2023-10-10
First Post:
2016-10-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor:
Philogen S.p.A.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Acute Myeloid Leukemia, Relapsed, Adult | View |
Keywords: